GO:0044281 | small molecule metabolic process | 8.36e-06 | 1.21e-01 | 3.159 | 6 | 58 | 1211 |
GO:0005838 | proteasome regulatory particle | 1.77e-05 | 2.56e-01 | 8.231 | 2 | 7 | 12 |
GO:0022624 | proteasome accessory complex | 3.65e-05 | 5.26e-01 | 7.729 | 2 | 8 | 17 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.78e-05 | 1.00e+00 | 4.983 | 3 | 20 | 171 |
GO:0006099 | tricarboxylic acid cycle | 1.01e-04 | 1.00e+00 | 7.009 | 2 | 4 | 28 |
GO:0016032 | viral process | 1.15e-04 | 1.00e+00 | 3.755 | 4 | 55 | 534 |
GO:0016071 | mRNA metabolic process | 1.93e-04 | 1.00e+00 | 4.600 | 3 | 31 | 223 |
GO:0005759 | mitochondrial matrix | 2.06e-04 | 1.00e+00 | 4.568 | 3 | 14 | 228 |
GO:0016070 | RNA metabolic process | 2.61e-04 | 1.00e+00 | 4.453 | 3 | 32 | 247 |
GO:0006091 | generation of precursor metabolites and energy | 3.25e-04 | 1.00e+00 | 6.172 | 2 | 3 | 50 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.25e-04 | 1.00e+00 | 6.172 | 2 | 17 | 50 |
GO:0000502 | proteasome complex | 4.38e-04 | 1.00e+00 | 5.958 | 2 | 17 | 58 |
GO:0051087 | chaperone binding | 4.53e-04 | 1.00e+00 | 5.933 | 2 | 6 | 59 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.33e-04 | 1.00e+00 | 5.816 | 2 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.50e-04 | 1.00e+00 | 5.794 | 2 | 22 | 65 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.38e-04 | 1.00e+00 | 5.687 | 2 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.75e-04 | 1.00e+00 | 5.646 | 2 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.13e-04 | 1.00e+00 | 5.607 | 2 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.32e-04 | 1.00e+00 | 5.587 | 2 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.12e-04 | 1.00e+00 | 5.512 | 2 | 23 | 79 |
GO:0016020 | membrane | 8.83e-04 | 1.00e+00 | 2.423 | 5 | 90 | 1681 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.10e-03 | 1.00e+00 | 5.293 | 2 | 21 | 92 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0045252 | oxoglutarate dehydrogenase complex | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 2 | 2 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 2 | 2 |
GO:0003994 | aconitate hydratase activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0043066 | negative regulation of apoptotic process | 1.27e-03 | 1.00e+00 | 3.673 | 3 | 31 | 424 |
GO:0006458 | 'de novo' protein folding | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005218 | intracellular ligand-gated calcium channel activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0015085 | calcium ion transmembrane transporter activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 2 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0050882 | voluntary musculoskeletal movement | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0031094 | platelet dense tubular network | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0000209 | protein polyubiquitination | 1.74e-03 | 1.00e+00 | 4.958 | 2 | 20 | 116 |
GO:0044237 | cellular metabolic process | 1.77e-03 | 1.00e+00 | 4.946 | 2 | 5 | 117 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006104 | succinyl-CoA metabolic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006734 | NADH metabolic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0005955 | calcineurin complex | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 2 | 4 |
GO:0016887 | ATPase activity | 2.52e-03 | 1.00e+00 | 4.687 | 2 | 7 | 140 |
GO:0031088 | platelet dense granule membrane | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.85e-03 | 1.00e+00 | 4.597 | 2 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 2.89e-03 | 1.00e+00 | 4.587 | 2 | 24 | 150 |
GO:0003688 | DNA replication origin binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0021695 | cerebellar cortex development | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0006101 | citrate metabolic process | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0006554 | lysine catabolic process | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 2 | 8 |
GO:0051604 | protein maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0010467 | gene expression | 4.67e-03 | 1.00e+00 | 3.015 | 3 | 59 | 669 |
GO:0031095 | platelet dense tubular network membrane | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0048016 | inositol phosphate-mediated signaling | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0005829 | cytosol | 5.45e-03 | 1.00e+00 | 1.853 | 5 | 132 | 2496 |
GO:0006098 | pentose-phosphate shunt | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 4 | 10 |
GO:0043032 | positive regulation of macrophage activation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0019855 | calcium channel inhibitor activity | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0021756 | striatum development | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0021794 | thalamus development | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0032727 | positive regulation of interferon-alpha production | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0001530 | lipopolysaccharide binding | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 3 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0042026 | protein refolding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0006103 | 2-oxoglutarate metabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0017025 | TBP-class protein binding | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 3 | 17 |
GO:0050870 | positive regulation of T cell activation | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0032733 | positive regulation of interleukin-10 production | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0006200 | ATP catabolic process | 1.06e-02 | 1.00e+00 | 3.626 | 2 | 15 | 292 |
GO:0042100 | B cell proliferation | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 2 | 23 |
GO:0005637 | nuclear inner membrane | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:0042113 | B cell activation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 25 |
GO:0005739 | mitochondrion | 1.42e-02 | 1.00e+00 | 2.438 | 3 | 28 | 998 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 26 |
GO:0043022 | ribosome binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0050661 | NADP binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0016529 | sarcoplasmic reticulum | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 30 |
GO:0044822 | poly(A) RNA binding | 1.66e-02 | 1.00e+00 | 2.357 | 3 | 49 | 1056 |
GO:0031072 | heat shock protein binding | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 33 |
GO:0000278 | mitotic cell cycle | 1.84e-02 | 1.00e+00 | 3.205 | 2 | 48 | 391 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 3 | 35 |
GO:0032755 | positive regulation of interleukin-6 production | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 36 |
GO:0021766 | hippocampus development | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 4 | 38 |
GO:0006096 | glycolytic process | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 4 | 38 |
GO:0032729 | positive regulation of interferon-gamma production | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 39 |
GO:0042110 | T cell activation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 42 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 2 | 50 |
GO:0005905 | coated pit | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0031966 | mitochondrial membrane | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 1 | 55 |
GO:0007202 | activation of phospholipase C activity | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 3 | 55 |
GO:0002039 | p53 binding | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 7 | 55 |
GO:0070062 | extracellular vesicular exosome | 3.05e-02 | 1.00e+00 | 1.587 | 4 | 104 | 2400 |
GO:0035091 | phosphatidylinositol binding | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 3 | 61 |
GO:0030141 | secretory granule | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 2 | 62 |
GO:0006915 | apoptotic process | 3.55e-02 | 1.00e+00 | 2.700 | 2 | 33 | 555 |
GO:0003697 | single-stranded DNA binding | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 5 | 68 |
GO:0006816 | calcium ion transport | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 2 | 72 |
GO:0009791 | post-embryonic development | 3.98e-02 | 1.00e+00 | 4.626 | 1 | 2 | 73 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 7 | 77 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 3 | 80 |
GO:0050796 | regulation of insulin secretion | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 4 | 81 |
GO:0019083 | viral transcription | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 10 | 81 |
GO:0006415 | translational termination | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 10 | 87 |
GO:0050821 | protein stabilization | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 2 | 88 |
GO:0006414 | translational elongation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 13 | 93 |
GO:0051082 | unfolded protein binding | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 5 | 93 |
GO:0070588 | calcium ion transmembrane transport | 5.15e-02 | 1.00e+00 | 4.246 | 1 | 2 | 95 |
GO:0006112 | energy reserve metabolic process | 5.15e-02 | 1.00e+00 | 4.246 | 1 | 3 | 95 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 4 | 105 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.15e-02 | 1.00e+00 | 3.983 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 13 | 115 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 126 |
GO:0006413 | translational initiation | 7.04e-02 | 1.00e+00 | 3.783 | 1 | 17 | 131 |
GO:0005634 | nucleus | 7.14e-02 | 1.00e+00 | 0.984 | 5 | 136 | 4559 |
GO:0003735 | structural constituent of ribosome | 7.35e-02 | 1.00e+00 | 3.718 | 1 | 10 | 137 |
GO:0001666 | response to hypoxia | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 5 | 149 |
GO:0005769 | early endosome | 8.13e-02 | 1.00e+00 | 3.568 | 1 | 2 | 152 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 8.33e-02 | 1.00e+00 | 3.531 | 1 | 9 | 156 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 8.95e-02 | 1.00e+00 | 3.424 | 1 | 12 | 168 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 12 | 189 |
GO:0030168 | platelet activation | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 10 | 205 |
GO:0005654 | nucleoplasm | 1.16e-01 | 1.00e+00 | 1.737 | 2 | 76 | 1082 |
GO:0006412 | translation | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 20 | 230 |
GO:0005975 | carbohydrate metabolic process | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 9 | 253 |
GO:0043065 | positive regulation of apoptotic process | 1.39e-01 | 1.00e+00 | 2.750 | 1 | 10 | 268 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.40e-01 | 1.00e+00 | 2.745 | 1 | 15 | 269 |
GO:0005743 | mitochondrial inner membrane | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 8 | 277 |
GO:0043234 | protein complex | 1.52e-01 | 1.00e+00 | 2.612 | 1 | 18 | 295 |
GO:0005524 | ATP binding | 1.58e-01 | 1.00e+00 | 1.474 | 2 | 60 | 1298 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0005515 | protein binding | 2.02e-01 | 1.00e+00 | 0.582 | 5 | 184 | 6024 |
GO:0009986 | cell surface | 2.02e-01 | 1.00e+00 | 2.165 | 1 | 11 | 402 |
GO:0055114 | oxidation-reduction process | 2.11e-01 | 1.00e+00 | 2.102 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0005730 | nucleolus | 2.29e-01 | 1.00e+00 | 1.136 | 2 | 69 | 1641 |
GO:0044267 | cellular protein metabolic process | 2.35e-01 | 1.00e+00 | 1.927 | 1 | 29 | 474 |
GO:0005783 | endoplasmic reticulum | 2.70e-01 | 1.00e+00 | 1.697 | 1 | 10 | 556 |
GO:0005789 | endoplasmic reticulum membrane | 2.76e-01 | 1.00e+00 | 1.661 | 1 | 16 | 570 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 24 | 596 |
GO:0005737 | cytoplasm | 3.49e-01 | 1.00e+00 | 0.522 | 3 | 110 | 3767 |
GO:0007165 | signal transduction | 4.05e-01 | 1.00e+00 | 0.991 | 1 | 24 | 907 |
GO:0005615 | extracellular space | 4.23e-01 | 1.00e+00 | 0.914 | 1 | 17 | 957 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 45 | 2582 |
GO:0046872 | metal ion binding | 5.32e-01 | 1.00e+00 | 0.464 | 1 | 25 | 1307 |
GO:0016021 | integral component of membrane | 6.94e-01 | 1.00e+00 | -0.137 | 1 | 27 | 1982 |